Pegfilgrastim biosimilar - Dr Reddy's Laboratories

Drug Profile

Pegfilgrastim biosimilar - Dr Reddy's Laboratories

Alternative Names: DRL_PG; Peg-grafeel; Recombinant pegylated human granulocyte colony stimulating factor - Dr Reddy's Laboratories

Latest Information Update: 19 Sep 2014

Price : $50

At a glance

  • Originator Dr Reddys Laboratories
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Polyethylene glycols; Recombinant proteins
  • Mechanism of Action Granulocyte stimulants; Haematopoiesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Neutropenia

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 28 Feb 2014 Phase-I clinical trials in Neutropenia (In volunteers) in USA (SC)
  • 10 May 2011 Launched for Neutropenia in India (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top